SG Americas Securities’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

SG Americas Securities’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-93,615	Closed	-$1.17M	–	3749
2016 Q4	$1.17M	Buy	93,615 +58,226	+165%	+$701K	0.01%	1211
2016 Q3	$484K	Buy	+35,389	New	+$355K	0.01%	1736
2016 Q2	–	Sell	-12,558	Closed	-$80K	–	3241
2016 Q1	$80K	Buy	+12,558	New	+$70.4K	﹤0.01%	2681
2015 Q4	–	Sell	-24,024	Closed	-$140K	–	3178
2015 Q3	$140K	Buy	+24,024	New	+$185K	﹤0.01%	1667
2015 Q2	–	Sell	-19,656	Closed	-$162K	–	2985
2015 Q1	$162K	Sell	19,656 -5,017	-20%	-$37.1K	﹤0.01%	1999
2014 Q4	$170K	Buy	+24,673	New	+$154K	﹤0.01%	2553

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

SG Americas Securities's ARIA Position: Q1 2017 in Review

SG Americas Securities sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 93,615 shares — an estimated $1.17M sold.

SG Americas Securities first reported a position in ARIA in Q4 2014 and held it in 6 quarters. The position peaked at $1.17M in Q4 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

SG Americas Securities reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
SG Americas Securities sold 93,615 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $1.17M.
SG Americas Securities first reported a position in Ariad Pharmaceuticals Inc in Q4 2014 and held it in 6 quarters.
SG Americas Securities's Ariad Pharmaceuticals Inc position peaked at $1.17M in Q4 2016.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on SG Americas Securities's 13F filing for Q1 2017, filed 10 May 2017.